Suppr超能文献

通过合理设计工程化调控小鼠细胞命运。

Engineering mouse cell fate controller by rational design.

机构信息

College of Life Sciences, Zhejiang University, Hangzhou, China.

Laboratory of Cell Fate Control, School of Life Sciences, Westlake University, Hangzhou, China.

出版信息

Nat Commun. 2024 Jul 23;15(1):6200. doi: 10.1038/s41467-024-50551-2.

Abstract

Cell fate is likely regulated by a common machinery, while components of this machine remain to be identified. Here we report the design and testing of engineered cell fate controller Nanog, fusing BiD or BRG1 interacting domain of SS18 with Nanog. Nanog promotes mouse somatic cell reprogramming efficiently in contrast to the ineffective native protein under multiple testing conditions. Mechanistic studies further reveal that it facilitates cell fate transition by recruiting the intended Brg/Brahma-associated factor (BAF) complex to modulate chromatin accessibility and reorganize cell state specific enhancers known to be occupied by canonical Nanog, resulting in precocious activation of multiple genes including Sall4, miR-302, Dppa5a and Sox15 towards pluripotency. Although we have yet to test our approach in other species, our findings suggest that engineered chromatin regulators may provide much needed tools to engineer cell fate in the cells as drugs era.

摘要

细胞命运可能受到共同机制的调控,而这种机制的组成部分仍有待确定。在这里,我们报告了工程化细胞命运控制器 Nanog 的设计和测试,它融合了 SS18 的 BiD 或 BRG1 相互作用域与 Nanog。在多种测试条件下,与无效的天然蛋白相比,Nanog 有效地促进了小鼠体细胞重编程。机制研究进一步表明,它通过招募预期的 Brg/Brahma 相关因子(BAF)复合物来调节染色质可及性,并重新组织已知被经典 Nanog 占据的细胞状态特异性增强子,从而促进多个基因的过早激活,包括 Sall4、miR-302、Dppa5a 和 Sox15 向多能性。尽管我们尚未在其他物种中测试我们的方法,但我们的发现表明,工程化染色质调节剂可能为细胞命运工程提供急需的工具,作为药物时代的一种方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f4/11266670/fc4ba4373298/41467_2024_50551_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验